Literature DB >> 27591126

PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering.

Bertrand Cariou1, Zufeng Ding2, Jawahar L Mehta3.   

Abstract

Entities:  

Keywords:  Atherosclerosis; Coronary restenosis; Extra-hepatic; PCSK9; Vascular smooth muscle cell

Mesh：

Substances：

Year:  2016        PMID： 27591126     DOI： 10.1016/j.atherosclerosis.2016.08.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  3 in total

1.  FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.

Authors:  Gopala K Yakala; Hector A Cabrera-Fuentes; Gustavo E Crespo-Avilan; Chutima Rattanasopa; Alexandrina Burlacu; Benjamin L George; Kaviya Anand; David Castaño Mayan; Maria Corlianò; Sauri Hernández-Reséndiz; Zihao Wu; Anne M K Schwerk; Amberlyn L J Tan; Laia Trigueros-Motos; Raphael Chèvre; Tricia Chua; Robert Kleemann; Elisa A Liehn; Derek J Hausenloy; Sujoy Ghosh; Roshni R Singaraja
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

2.  Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis.

Authors:  Yimo Zhou; Weiqi Chen; Meng Lu; Yongjun Wang
Journal:  Front Cardiovasc Med       Date:  2021-03-02

Review 3.  PCSK9 Biology and Its Role in Atherothrombosis.

Authors:  Cristina Barale; Elena Melchionda; Alessandro Morotti; Isabella Russo
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.